|
|
||||||||||||||||||||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||||
In case of anthrax attack: Public health guidelinesMay 11, 1999 BALTIMORE (CNN) -- In the unlikely event that the deadly and invisible anthrax organism is ever released in the air of a populated area, U.S. doctors and public health directors now have guidelines for how to respond. The recommendations appear in the May 12 issue of the Journal of the American Medical Association. Dr. Thomas Inglesby of Johns Hopkins University and colleagues in the Working Group on Civilian Biodefense wrote that anthrax, one of numerous biological agents that could be used as weapons, could cripple a city or region. They cite a 1993 report that estimated the aerosolized release of 100 kilograms of anthrax spore upwind of Washington, D.C., could kill 130,000 to 3 million people -- matching or exceeding the lethal effects of a hydrogen bomb. According to the report, anthrax is odorless, invisible and could travel miles through the air. They say the first evidence of an anthrax attack could be "the sudden appearance of a large number of patients in a city or region with an acute-onset, flu-like illness and case fatality rates of 80 percent or more, with nearly half of all deaths occurring within 24 to 48 hours." Naturally occurring anthrax is a bacteria that infects animals. Livestock are usually vaccinated against the disease. The more usual ways humans become infected include handling material from infected animals and inhaling anthrax spores from infected animal materials. Human cases of anthrax are extremely rare in the United States. If recognized in the initial stages of infection, anthrax is easily controlled with antibiotics. However, the initial symptoms, which include fever, difficulty breathing, shortness of breath, coughing, headache, vomiting, chills, weakness, abdominal pain and chest pain, are difficult to distinguish from a number of illnesses. In the event of a bioterrorist attack with anthrax, the Working Group on Civilian Biodefense recommended:
"Most experts concur that the manufacture of a lethal anthrax aerosol is beyond the capacity of individuals or groups without access to advanced biotechnology," the authors wrote. "However, autonomous groups with substantial funding and contacts may be able to acquire the required materials for a successful attack," the report concluded. RELATED STORIES: Inspecting Iraq: Weapons effects Clinton puts roadblock on terrorist superhighway RELATED SITES: JAMA - The Journal of the American Medical Association
LATEST HEALTH STORIES: China SARS numbers pass 5,000
| ||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||
| Back to the top |
© 2001 Cable News Network. All Rights Reserved. Terms under which this service is provided to you. Read our privacy guidelines. |